1. Home
  2. CC vs SUPN Comparison

CC vs SUPN Comparison

Compare CC & SUPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Chemours Company (The)

CC

Chemours Company (The)

HOLD

Current Price

$17.18

Market Cap

2.9B

Sector

Industrials

ML Signal

HOLD

Logo Supernus Pharmaceuticals Inc.

SUPN

Supernus Pharmaceuticals Inc.

HOLD

Current Price

$48.16

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CC
SUPN
Founded
2014
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.9B
2.8B
IPO Year
2014
2010

Fundamental Metrics

Financial Performance
Metric
CC
SUPN
Price
$17.18
$48.16
Analyst Decision
Buy
Strong Buy
Analyst Count
9
5
Target Price
$20.11
$61.60
AVG Volume (30 Days)
2.8M
916.2K
Earning Date
05-05-2026
05-05-2026
Dividend Yield
1.33%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$6,638,000,000.00
$392,755,000.00
Revenue This Year
$6.15
$22.70
Revenue Next Year
$5.95
$19.14
P/E Ratio
N/A
N/A
Revenue Growth
7.36
N/A
52 Week Low
$10.44
$32.21
52 Week High
$28.67
$59.68

Technical Indicators

Market Signals
Indicator
CC
SUPN
Relative Strength Index (RSI) 34.34 54.81
Support Level $15.99 $47.48
Resistance Level $23.63 $52.24
Average True Range (ATR) 1.10 1.66
MACD -0.11 0.13
Stochastic Oscillator 1.30 49.92

Price Performance

Historical Comparison
CC
SUPN

About CC Chemours Company (The)

The Chemours Co is a provider of chemicals. It delivers customized solutions with a wide range of industrial and specialty chemicals products for various markets including coatings, plastics, refrigeration, air conditioning, paints and coatings, plastics, transportation, semiconductor, and others. The company's operating segments include Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. It generates maximum revenue from the Titanium Technologies segment. The Titanium Technologies segment is a producer of TiO2 pigment, a premium white pigment used to deliver whiteness, brightness, opacity, durability, efficiency, and protection across a variety of applications. Geographically, the company derives a majority of its revenue from North America.

About SUPN Supernus Pharmaceuticals Inc.

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, Osmolex ER, and others.

Share on Social Networks: